Shu‐Jen Chen

8.1k total citations · 1 hit paper
152 papers, 5.9k citations indexed

About

Shu‐Jen Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shu‐Jen Chen has authored 152 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 30 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Shu‐Jen Chen's work include Virus-based gene therapy research (16 papers), Cancer Genomics and Diagnostics (13 papers) and MicroRNA in disease regulation (13 papers). Shu‐Jen Chen is often cited by papers focused on Virus-based gene therapy research (16 papers), Cancer Genomics and Diagnostics (13 papers) and MicroRNA in disease regulation (13 papers). Shu‐Jen Chen collaborates with scholars based in Taiwan, United States and United Kingdom. Shu‐Jen Chen's co-authors include Ching-Lai Hwang, James M. Wilson, Hua‐Chien Chen, Teh‐Liang Chen, Yasuji Mori, Yu‐Sun Chang, John Varga, Ruey‐Chi Wang, Krishna J. Fisher and Ren-Bin Tang and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shu‐Jen Chen

150 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fuzzy Multiple Attribute Decision Making

1992 1.4k citations Shu‐Jen Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu‐Jen Chen Taiwan	37	2.3k	964	866	843	744	152	5.9k
Zan Huang China	50	2.6k 1.1×	602 0.6×	404 0.5×	505 0.6×	609 0.8×	197	8.5k
George Wright United States	19	2.8k 1.2×	551 0.6×	340 0.4×	545 0.6×	831 1.1×	46	5.7k
Lu Zhang China	42	1.2k 0.5×	257 0.3×	398 0.5×	1.1k 1.3×	541 0.7×	207	10.1k
Ming‐Wei Lin Taiwan	58	1.4k 0.6×	553 0.6×	1.6k 1.8×	359 0.4×	210 0.3×	395	13.0k
Yong‐Jun Liu China	68	4.0k 1.7×	1.4k 1.4×	767 0.9×	2.4k 2.9×	635 0.9×	203	20.2k
Christian Hafner Germany	42	1.5k 0.6×	820 0.9×	227 0.3×	890 1.1×	323 0.4×	190	5.7k
Zhi Wei United States	39	3.2k 1.4×	966 1.0×	107 0.1×	908 1.1×	838 1.1×	259	6.2k
Guoliang Li China	49	4.6k 2.0×	1.0k 1.1×	169 0.2×	558 0.7×	856 1.2×	277	8.2k
Linda K. Green United States	40	774 0.3×	640 0.7×	256 0.3×	922 1.1×	364 0.5×	173	6.1k
Mei‐Ling Ting Lee United States	29	2.0k 0.9×	238 0.2×	300 0.3×	246 0.3×	1.0k 1.3×	103	5.2k

Countries citing papers authored by Shu‐Jen Chen

Since Specialization

Citations

This map shows the geographic impact of Shu‐Jen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Jen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Jen Chen more than expected).

Fields of papers citing papers by Shu‐Jen Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Jen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Jen Chen. The network helps show where Shu‐Jen Chen may publish in the future.

Co-authorship network of co-authors of Shu‐Jen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Jen Chen. A scholar is included among the top collaborators of Shu‐Jen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Jen Chen. Shu‐Jen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Yu‐Cheng, Hui‐Jen Tsai, Yi-Fang Chang, et al.. (2024). Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations. Annals of Hematology. 103(8). 2917–2930. 3 indexed citations

Chang, John Wen‐Cheng, Wen‐Kuan Huang, Yu‐Chao Wang, et al.. (2023). Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. Clinical & Translational Immunology. 12(8). e1465–e1465. 2 indexed citations

Jan, Yi‐Hua, et al.. (2022). Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing. British Journal of Cancer. 127(7). 1304–1311. 17 indexed citations

Tan, Kien Thiam, Li‐Yuan Bai, Chin‐Fu Hsiao, et al.. (2022). Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study. Clinical Cancer Research. 28(19). 4248–4257. 13 indexed citations

Lin, Po‐Han, Ling‐Ming Tseng, Yi‐Hsuan Lee, et al.. (2022). Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders. Journal of the Formosan Medical Association. 121(12). 2538–2547. 11 indexed citations

Sims, Joshua J., Jenny A. Greig, Kristofer T. Michalson, et al.. (2021). Intranasal gene therapy to prevent infection by SARS-CoV-2 variants. PLoS Pathogens. 17(7). e1009544–e1009544. 28 indexed citations

Hsu, Hung‐Chih, Chuang‐Wei Wang, Pei‐Yi Lin, et al.. (2018). Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer. Molecular Cancer Therapeutics. 17(10). 2238–2247. 24 indexed citations

Greig, Jenny A., Maria P. Limberis, Peter Bell, et al.. (2017). Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR ^+/− Rhesus Macaques. Europe PMC (PubMed Central). 28(1). 39–50. 44 indexed citations

Chen, Shu‐Jen, Pei‐Chen Tsao, Chih‐Chien Wang, et al.. (2017). The analgesic effect of non-pharmacological interventions to reduce procedural pain in preterm neonates. Pediatrics & Neonatology. 59(1). 71–76. 26 indexed citations

10.

Chao, Angel, Ren‐Chin Wu, Shih‐Ming Jung, et al.. (2016). Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology. Gynecologic Oncology. 143(1). 60–67. 48 indexed citations

11.

Chen, Shu‐Jen, et al.. (2014). Comparison of Blood Pressure in Mature and Premature Neonates Using Direct and Indirect Methods of Measurement. 1 indexed citations

12.

Lin, Chih‐Ming, et al.. (2013). Grating-Coupled Surface-Plasmon-Resonance Disc Biosensor for Monitoring Growth of Self-Assembled Monolayer. Sensors and Materials. 371–371. 1 indexed citations

13.

Huang, Yi, et al.. (2012). Identification of a two-layer regulatory network of proliferation-related microRNAs in hepatoma cells. Nucleic Acids Research. 40(20). 10478–10493. 33 indexed citations

14.

Chen, Hua‐Chien, Yun‐Shien Lee, Martin A. Sieber, et al.. (2011). MicroRNA and Messenger RNA Analyses of Mesenchymal Stem Cells Derived from Teeth and the Wharton Jelly of Umbilical Cord. Stem Cells and Development. 21(6). 911–922. 18 indexed citations

15.

Chen, Shu‐Jen, et al.. (2010). Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing. PLoS ONE. 5(9). e12745–e12745. 161 indexed citations

16.

Chen, Yu‐Cheng, Shu‐Jen Chen, Ming-Chung Chang, & Teh‐Liang Chen. (2005). Comparison of various methods for periplasmic release of recombinant creatinase from Escherichia coli. Journal of The Chinese Institute of Chemical Engineers. 36(5). 527–532. 3 indexed citations

17.

Ghosh, Asish K., Swati Bhattacharyya, Gabriella Lakos, et al.. (2004). Disruption of transforming growth factor β signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator–activated receptor γ. Arthritis & Rheumatism. 50(4). 1305–1318. 170 indexed citations

18.

Schnell, Michael A., Yi Zhang, John Tazelaar, et al.. (2001). Activation of Innate Immunity in Nonhuman Primates Following Intraportal Administration of Adenoviral Vectors. Molecular Therapy. 3(5). 708–722. 272 indexed citations

19.

Shen, Ya‐Ching, et al.. (2000). Bioactive Steroids from the Formosan Gorgonian Isis Hippuris. Zhōnghuá yàoxué zázhì. 52(6). 341–351. 2 indexed citations

20.

Brysk, Miriam M., et al.. (1986). Modified Distribution of Epidermal Glycoproteins in the Nude Mouse. Pathobiology. 54(3). 163–169. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact